U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07844057) titled 'First-line Treatment in Locally Advanced or Metastastic Small Bowel Adenocarcinoma' on Sept. 22.
Brief Summary: Phase II randomized trial evaluating modified FOLFIRINOX and FOLFOX in the treatment of locally advanced or metastatic small bowel adenocarcinoma
Study Start Date: Oct. 01
Study Type: INTERVENTIONAL
Condition:
Small-bowel Adenocarcinoma
Metastatic Disease
Chemotherapy Effect
Intervention:
DRUG: mFOLFIRINOX versus FOLFOX chemotherapy
Systemic treatment in both arms will be continued until disease progression, occurence of unacceptable toxicity, at the patient's request, at discretion of the investigator, whatever oc...